PRKG1 Blocks Muscle Differentiation, Predicts Drug Response
Rhabdomyosarcoma (RMS), a malignant tumor arising from skeletal muscle progenitors, continues to pose significant therapeutic challenges due to its aggressive nature and resistance to conventional...
















